心房颤动(AF)是最常见的心律失常,占全球心律失常性疾病和心脏栓塞性脑卒中病因第一位。早期处理将有助于降低与AF相关的病死率及罹患率。有靶向的药物治疗,通过改变底物而防止AF的进展。发现肺静脉起触发作用是个大的突破,并因此产生了肺静脉消融——对药物治疗无效病人的一种 Atrial fibrillation (AF) is the most common arrhythmia, accounting for the leading cause of global arrhythmic and cardiac embolic stroke. Early treatment will help reduce mortality and morbidity associated with AF. Targeted drug therapy prevents the progression of AF by changing the substrate. Finding pulmonary veins to trigger was a major breakthrough and resulted in pulmonary vein ablation - a type of drug that was ineffective